Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie

26. Mars 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Troubles de la motilité

Écriture:

Page 1 de 1926


	Articles 1 - 20 / 38504

	Evaluating the adaptation rates for esophageal cancer: Impact of the setup error contribution and of the dosimetric threshold. Phys Med Draguet C, Populaire P, Vera MC, Haustermans K, Lee JA, Barragán-Montero AM, Sterpin E. PMID: 41880866 [PubMed - as supplied by publisher]
	Limited lymphadenectomy for elderly patient with gastric cancer: a systematic review and meta-analysis. Gastric Cancer Miki Y, Bito T, Makuuchi R, Ishizu K, Shintani A, Terashima M. PMID: 41879959 [PubMed - as supplied by publisher]
	The palmitoylation enzyme ZDHHC2 promotes esophageal cancer progression via N-acetylaspartylglutamate. Discov Oncol Peng S, Wang J, Zhou F, Song Z. PMID: 41879913 [PubMed - as supplied by publisher]
	Neoadjuvant Therapy for Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma: Current Status, Challenges, and Future Perspectives. Cancer Med Zhou J, Guo C, Zhang M, Guo X, Wang J, Liu X, Nie P, Ma Y. PMID: 41876949 [PubMed - indexed for MEDLINE]
	Prognostic value of the C-PLAN index in patients with advanced esophageal cancer treated with immune checkpoint inhibitors. Clinics (Sao Paulo) Shao S, Zhang H, Gu Y, Yang X, Huang J. PMID: 41875627 [PubMed - as supplied by publisher]
	Adenoid Cystic Carcinoma of the Bartholin Gland: A Case Report. Cureus Bombon MF, Alarcon CJ, Reyes JL, Plaza JS, Plaza GG. PMID: 41873313 [PubMed]
	Assessing diagnostic accuracy of circulating microRNAs as biomarkers for ovarian cancer: a systematic review and meta-analysis. J Ovarian Res Iqbal MO, Bukhari AAS, Ali A, Gu Y, Chen J, Zhang B. PMID: 41872961 [PubMed - as supplied by publisher]
	Impact of lymphatic ablation approaches on immunotherapy efficacy in advanced/metastatic esophageal squamous cell carcinoma: A multi-institutional retrospective cohort study. Int J Cancer Liu Y, Li B, Wang Z, Zheng S, Zhang X, Qiu X, Jiang Z, Dong T, Jiang C, Du C, Wang L. PMID: 41872730 [PubMed - as supplied by publisher]
	The Association of a Positive Fecal Immunochemical Test With the Risk of Gastroesophageal Cancer: An Age-Sex-H.â€‰Pylori Exposure Matched Cohort Study and Cost-Effectiveness Analysis. Helicobacter Levi Z, Abu-Freha N, Boltin D, Golan MA, Konikoff T, Arbib OS, Belfer RG, Eizenstein S, Vilkin A, Kusnir S, Turgeman A, Babich T, Leshno M, Flugelman AA, Edelman-Klapper H, Half-Onn E. PMID: 41872706 [PubMed - indexed for MEDLINE]
	Minimally invasive salvage esophagectomy following definitive chemoradiotherapy for esophageal cancer. Dis Esophagus Tsunoda S, Nishigori T, Okumura S, Hisamori S, Kasahara K, Sakamoto T, Morimoto T, Kinoshita H, Obama K. PMID: 41870125 [PubMed - indexed for MEDLINE]
	Efficacy and Safety of Conversion Surgery Versus Non-Surgical Treatment for Initially Unresectable Esophageal Cancer: A Systematic Review and Meta-Analysis. J Gastrointest Cancer Chen L, Zhao J, Luo X. PMID: 41866651 [PubMed - in process]
	Novel Prediction of Postoperative Pneumonia in Elderly Patients With Esophageal Cancer Undergoing Minimally Invasive Esophagectomy Using Dementia Assessment Sheet for Community-Based Integrated Care System 21-Items (DASC-21). Asian J Endosc Surg Nakai T, Kitadani J, Hayata K, Goda T, Tominaga S, Fukuda N, Nagano S, Kawai M. PMID: 41866224 [PubMed - indexed for MEDLINE]
	Effects of a whole-course individualized comprehensive nursing program on anastomotic leakage incidence and patient outcomes after esophageal cancer surgery. J Gastrointest Surg Yan LH, Li Y, Zhang M, Lu Y, Ben LY, Xu YM. PMID: 41864323 [PubMed - as supplied by publisher]
	Real-World Efficacy of Nab-Paclitaxel Plus Capecitabine and a PD-1 Inhibitor in Metastatic or Locally Advanced Esophageal Cancer. Cancer Med Wang Y, Zhang WJ, Lu YX, Liu SL, Zhang ZY, Zhang SM, Wang TW, Zhong Y, Zhang DS. PMID: 41862176 [PubMed - indexed for MEDLINE]
	Beneficial subgroups for PD-1 inhibitor plus chemotherapy in first-line treatment of advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis. Medicine (Baltimore) Gao R, Wang D, Su L, Zhang X, Dai T. PMID: 41861173 [PubMed - indexed for MEDLINE]
	Life After Esophageal Cancer-Loss, Eating Challenges, and Reclaiming Control: A Qualitative Study of Rehabilitation, Late Effects, and Support Needs Among Patients and Informal Caregivers. Cancer Nurs Larsen MK, Missel M, Roy LC. PMID: 41860567 [PubMed - as supplied by publisher]
	Contrasting roles of PD-L1 expression in tumor and stroma: Biological and prognostic implications in esophageal squamous cell carcinoma. Histol Histopathol Booka E, Murakami T, Takeuchi H. PMID: 41859819 [PubMed - as supplied by publisher]
	Analyses on patterns of lymph node metastasis and its impact on prognosis in thoracic esophageal squamous cell carcinoma treated with neoadjuvant immunochemotherapy versus chemotherapy alone: a single-center, retrospective cohort study. Front Immunol Liu W, Deng Y, Zheng X, Su W, Zheng J, Lin Y, Xiao W, Shi Y, Zhang J, Fang W, Chen X. PMID: 41859128 [PubMed - indexed for MEDLINE]
	Hypoxia-related and immune phenotype-related fusion model for non-invasive prognostication of hepatocellular carcinoma treated by TACE: a multicentre study. Gut Guo Y, Zhang G, Fu X, Jiang S, Li Y, Li S, Guo X, Zhang X, Zhao C, Ding R, Yu L, Yang X, Zhao K, Sun Y, Liu Q, Zhang Y, Duan X, Zhao H, Zou J, Liang B, Yang L, Zheng C, Kan X. PMID: 41856522 [PubMed - as supplied by publisher]
	A New Cloud-Model-Based Prognostic Model for Gastric Carcinoma. Technol Cancer Res Treat Liu K, Suo X, He T, Wang Y, Li D, Zhang Y, Chen Z, Mu K, Jiang P, Wei X, Jiao Y, Gao S. PMID: 41854371 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 38504

Page 1 de 1926



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité